Fmoc-L-Cyclohexylglycin

Fmoc-L-Cyclohexylglycin is an Fmoc-protected amino acid derivative in which the amino acid backbone is substituted with a cyclohexyl side chain, classifying it as a nonpolar, bulky, hydrophobic amino acid analogue for peptide chemistry. The molecule bears an Fmoc (9-fluorenylmethoxycarbonyl) protecting group on the α-amino functionality while retaining a free carboxylic acid, and the "L" designation indicates the specified stereochemical configuration at the α-carbon. In synthesis, the Fmoc-protected form functions as a building block for stepwise peptide assembly under protected-amino-acid conditions, where the cyclohexyl side chain can be used to probe steric and hydrophobic effects in structure-activity studies or to prepare peptides with altered conformational and packing properties.

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.

CAT No: CP21108

CAS No:161321-36-4

Synonyms/Alias:Fmoc-Chg-OH;161321-36-4;Fmoc-L-Cyclohexylglycin;(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-cyclohexylaceticacid;AmbotzFAA1713;AC1OCVE4;SCHEMBL1405653;CTK8C5135;BWQQGHPODCJZDB-NRFANRHFSA-N;MolPort-006-705-652;ACT09756;ZINC1036845;8160AA;ANW-74306;CF-785;RTR-006866;AJ-24720;AK-63437;KB-52086;SC-11107;AB1002084;FT-0679772;J-300447;I14-38638;(2S)-2-cyclohexyl-2-(9H-fluoren-9-ylmethoxycarbonylamino)aceticacid

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
M.F/Formula
C23H25NO4
M.W/Mr.
379.5
Application
Peptide synthesis; Drug screening

Fmoc-L-Cyclohexylglycin is an Fmoc-protected L-amino acid derivative in which the chiral center of the cyclohexylglycine backbone is preserved for stereochemical fidelity during peptide assembly. The structure contains an Fmoc carbamate on the amino group, a free carboxyl functionality suitable for amide bond formation, and a cyclohexyl side chain that provides a hydrophobic, conformationally biasing substituent compared with aliphatic or aromatic analogs. The Fmoc group enables base-labile protection that is compatible with standard solid-phase peptide synthesis deprotection conditions, while the carboxylic acid participates in coupling chemistries to generate stable peptide bonds. The resulting protected amino acid is a chiral intermediate that can be carried through iterative protection, coupling, and deprotection steps, supporting downstream derivatization and structure-directed peptide or peptidomimetic construction.

1. Peptide Synthesis

Fmoc-L-Cyclohexylglycin is used in peptide synthesis workflows where Fmoc protection supports stepwise N-terminal assembly and controlled deprotection cycles. The amino acid ester/acid functionality is configured as the peptide-building block form, with the free carboxyl group enabling amide coupling to activated carboxyl derivatives or resin-bound amines. The cyclohexyl side chain contributes hydrophobic character and steric bulk that can influence local secondary structure propensity and solubility profiles of the growing chain. Incorporation into linear peptides and peptide fragments supports access to analog libraries for sequence optimization and synthetic methodology development in protected amino acid chemistry.

2. Peptidomimetics And SAR

Fmoc-L-Cyclohexylglycin is applied in peptidomimetic construction and structure-activity relationship studies where a conformationally restrained, hydrophobic side chain can modulate binding pocket interactions. The L-configuration at the backbone stereocenter ensures stereochemical consistency when generating analogs that probe side-chain effects on potency trends and selectivity patterns. The Fmoc-protected amine allows rapid generation of defined amide linkages, facilitating systematic variation of neighboring residues and spacing in SAR-focused peptide scaffolds. Downstream deprotection and fragment coupling can yield cyclohexylglycine-containing intermediates for medicinal chemistry campaigns that require chiral, sequence-defined building blocks.

3. Chemical Biology Labeling

Fmoc-L-Cyclohexylglycin is suitable for chemical biology research that requires incorporation of a hydrophobic, stereodefined amino acid into peptide probes or affinity reagents. The protected amino acid format supports controlled introduction into peptide sequences that later undergo functional group transformations at other handles, while the cyclohexyl side chain can tune membrane affinity and nonspecific binding behavior. Fmoc removal during synthesis exposes the amine for subsequent conjugation strategies, including attachment to linkers, tags, or reactive moieties positioned at termini or side-chain functional sites introduced elsewhere in the construct. The chiral backbone and stable amide linkage formation enable reproducible generation of labeled biomolecular fragments used in binding studies and molecular recognition assays.

4. Process Chemistry Intermediate

Fmoc-L-Cyclohexylglycin is employed as a chiral intermediate in process chemistry intermediate preparation for fine chemical synthesis routes that require Fmoc-protected amino acid handling. The Fmoc carbamate and carboxylic acid functionalities support robust protection/deprotection logic, allowing manufacturing processes to separate protection steps from coupling operations while maintaining stereochemical integrity. The cyclohexylglycine side chain provides a predictable hydrophobic motif that can be carried through downstream transformations into peptide-grade intermediates or protected fragments. The compound's compatibility with standard peptide coupling chemistry makes it suitable for scalable production of sequence-defined intermediates used in industrial peptide manufacturing and custom synthesis.

5. Protein Engineering Building Block

Fmoc-L-Cyclohexylglycin is used in protein engineering contexts where peptide or protein segment synthesis benefits from hydrophobic residue incorporation with preserved stereochemistry. The L-amino acid backbone and Fmoc-protected amine enable site-specific placement of cyclohexylglycine into engineered sequences during fragment assembly or peptide-based expression workflows. The bulky cyclohexyl side chain can affect local folding, packing interactions, and solvent exposure, supporting studies that examine how hydrophobic substitutions alter stability or conformational behavior. The resulting chiral building block supports generation of defined protein fragments and engineered constructs that can be further functionalized for biochemical characterization.

Abbr
Fmoc-Chg-OH
InChI
1S/C23H25NO4/c25-22(26)21(15-8-2-1-3-9-15)24-23(27)28-14-20-18-12-6-4-10-16(18)17-11-5-7-13-19(17)20/h4-7,10-13,15,20-21H,1-3,8-9,14H2,(H,24,27)(H,25,26)/t21-/m0/s1
InChI Key
BWQQGHPODCJZDB-NRFANRHFSA-N
Canonical SMILES
C1CCC(CC1)C(C(=O)O)NC(=O)OCC2C3=CC=CC=C3C4=CC=CC=C24

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
Peptide Modification ServicesEpitope Mapping ServicesPeptide CDMOPeptide Synthesis ServicesPeptide Analysis ServicescGMP Peptide ServiceCustom Conjugation ServicePeptide Nucleic Acids Synthesis
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers